Symbol="RIGL"
AssetType="Common Stock"
Name="Rigel Pharmaceuticals Inc"
Description="Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California."
CIK="1034842"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="217952000"
EBITDA="-43376000"
PERatio="None"
PEGRatio="-0.1"
BookValue="-0.14"
DividendPerShare="0"
DividendYield="0"
EPS="-0.26"
RevenuePerShareTTM="0.724"
ProfitMargin="-0.357"
OperatingMarginTTM="-0.356"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-6.99"
RevenueTTM="125077000"
GrossProfitTTM="53721000"
DilutedEPSTTM="-0.26"
QuarterlyEarningsGrowthYOY="0.745"
QuarterlyRevenueGrowthYOY="0.558"
AnalystTargetPrice="4.16"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.556"
PriceToBookRatio="31.64"
EVToRevenue="1.692"
EVToEBITDA="-1.948"
Beta="0.681"
num_52WeekHigh="2.04"
num_52WeekLow="0.668"
num_50DayMovingAverage="1.427"
num_200DayMovingAverage="1.288"
SharesOutstanding="173667000"
DividendDate="None"
ExDividendDate="None"
symbol="RIGL"
open="1.26"
high="1.29"
low="1.24"
price="1.27"
volume="1528838.00"
latest_trading_day="2023-07-26"
previous_close="1.25"
change="0.01"
change_percent="1.1952%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="2532991"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.46"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="1090"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0123.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="617"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
